Handelsavisen
prelaunch
Companies Basic Materials 300821.SZ
30
300821.SZ Shenzhen Stock Exchange Specialty Chemicals

Shandong Dongyue Organosilicon Materials Co Ltd

¥14,32
Open in Charts → Attach watcher ⌖
CNY
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
17,2B CNY
P/E
EV / Rev
Div yield
0,10 %
Op margin
-0,7 %
ROE
-0,4 %
Net margin
-0,5 %
Debt / equity
0,09
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Shandong Dongyue Organosilicon Materials Co Ltd produces and sells organosilicon materials, primarily used in the chemical industry for applications such as silicone resins, silicone oils, and silicone rubber.

Business. Shandong Dongyue Organosilicon Materials Co Ltd (300821.SZ) is a specialty chemicals company headquartered in China. The firm operates within the Basic Materials sector, focusing on the production and sale of organosilicon materials. It is primarily listed on the Shenzhen Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not available.

Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustrySpecialty Chemicals
ActivityChemicals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-0,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 300821.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 300821.SZ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Shandong Dongyue Organosilicon Materials Co Ltd (300821.SZ) is a specialty chemicals company headquartered in China. The firm operates within the Basic Materials sector, focusing on the production and sale of organosilicon materials. It is primarily listed on the Shenzhen Stock Exchange. Specific details regarding operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorBasic Materials
    Business sectorChemicals
    IndustrySpecialty Chemicals
    ActivityChemicals
    AI synthesis
    GENERATED

    The company's capital structure is characterized by a low debt-to-equity ratio of 0.09, indicating a conservative leverage position. However, the negative net income of -19.31 million CNY and an operating loss of -26.80 million CNY suggest financial stress. The liquidity position is mixed, with a current ratio of 2.44, but the company has negative net cash after subtracting total debt, signaling potential liquidity risk.

    Profitability metrics are weak, with a return on equity of -0.39% and a return on assets of -0.33%. The gross profit of 166.88 million CNY is significantly lower than the operating and net losses, indicating high operating costs or inefficiencies. These figures fall below the typical performance of the Specialty Chemicals industry, which usually maintains positive returns and higher gross margins.

    Geographically, the company's revenue is concentrated in China, with no disclosed international operations. Segment-wise, the company operates as a single business unit, which increases exposure to regional and industry-specific risks. The lack of diversification could amplify the impact of domestic economic or regulatory changes.

    The company's growth trajectory is uncertain, with no disclosed revenue growth in the most recent period. The operating cash flow of 215.19 million CNY and free cash flow of 314.38 million CNY suggest some cash generation, but the negative net income and operating income indicate that this is not translating into profitability. The capital expenditure of -21.41 million CNY shows some investment in growth, but the scale is limited.

    Risk factors include the company's negative net income and operating income, which raise concerns about its ability to sustain operations and meet obligations. The low dilution risk is supported by the absence of significant share issuance or dilution mechanisms in the recent financial data. However, the negative net cash position and the high price-to-book ratio of 3.88 suggest that the company may be overvalued relative to its tangible assets.

    Recent events include the latest financial filing, which discloses the company's negative net income and operating loss. No recent earnings call transcripts or significant regulatory filings have been reported, limiting insight into management's strategic direction or operational improvements.

    Key takeaways
    • The company has a low debt-to-equity ratio but is currently reporting negative net income and operating income.
    • The return on equity and return on assets are negative, indicating poor profitability.
    • The company's revenue is concentrated in a single geographic region and operates as a single business segment.
    • The company generates positive operating and free cash flows but is not translating this into profitability.
    • The company's valuation appears to be high relative to its tangible book value.
    • The risk of dilution is low, but the company's liquidity position is medium due to negative net cash after debt.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    ¥14,32
    Market cap
    ¥19.13B
    Enterprise value
    ¥19.56B
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    90.9x
    P / B
    3.9x
    P / Tangible book
    3.9x
    Tangible book
    ¥4.93B
    Net cash
    -¥432.3M
    Current ratio
    2.4
    Debt / equity
    0.1
    ROA
    -0.3%
    ROE
    -0.4%
    Cash conversion
    -1114.0%
    CapEx / revenue
    -0.6%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-0,7 %Bottom quartile
    Net Margin-0,5 %Bottom quartile
    ROE-0,4 %Bottom quartile
    Capex / Rev-0,6 %Above P75
    D/E0,09Above median
    Cash Conv-11,14Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • Shandong Dongyue Organosilicon Materials Co Ltd Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    300821.SZCanonical
    Shenzhen Stock Exchange · CNY

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage